Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Semin Oncol. 2016 Jun 14;43(4):453–463. doi: 10.1053/j.seminoncol.2016.06.003

Figure 2. DNA damage multiplex assay utilized on an MX-1 BRCA-deficient breast cancer xenograft 24 hours after beginning treatment with irinotecan at 7.5 mg/kg.

Figure 2

False color assignments are as follows: Rad51 (pink), pS343-Nbs1 (green), ERCC1 (cyan), and γH2AX (red). A representative 40× image is shown. Cells expressing both pS343-Nbs1 (green) and γH2AX (red) are yellow on the merged image. Scale bar = 20 µm.